Effects of a Digital Decision Support System on Diabetes Management in a Real-World Home Care Setting: Prospective Quasi-Experimental Feasibility and Implementation Study.
Katharina Maria Lichtenegger, Lara Scholle-Winkler, Julia Kopanz and 5 others
PMID 42784804WHAT IT FOUND
Fewer emergency admissions and lower morning glucose were recorded while home care nurses used structured nursing training, GlucoTab, physician-guided insulin initiation and standardized insulin titration protocols.
The small study cannot separate components.
Key findings
01During implementation, no diabetes-related emergency admissions or hospitalizations were observed; before implementation there were five emergency admissions and four hospitalizations, and after implementation there were four emergency admissions and two hospitalizations.
02Mean morning blood glucose decreased from 212 mg/dL before implementation to 162 mg/dL after implementation, and the proportion of measurements within 70 to 180 mg/dL was 39.0% before, 77% during, and 70.8% after.
03Nurse adherence to GlucoTab recommendations was 94.7% for blood glucose measurement frequency, 95.8% for basal insulin dose adjustment, 99.7% for basal insulin injections, 97.9% for bolus insulin injections, and 100% for titration time points.
STILL TO COME
How it was doneWhat they foundWhat it means for RNs
Read the rest of this summary
You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.
What it does not show
The study included only nine participants, so the results are descriptive and hypothesis generating rather than causal evidence of effectiveness. There was no control group and no inferential statistical analysis, so changes over time cannot be attributed to the intervention. The intervention was a bundle of structured nursing training, GlucoTab, physician-guided insulin initiation, and standardized titration protocols, so the contribution of any single component cannot be separated. The postimplementation phase was routine care after GlucoTab discontinuation, not a return to baseline, because training and workflow changes may have persisted. Only two sites in one region were studied, and the phases were six months before, three months during, and six months after implementation. Transferability to other settings is limited. Continuous glucose monitoring and formal usability testing were not used. One participant withdrew after an unrelated hospitalization, and one participant died. Eight participants were assessed after implementation.
Declared interests
Parts of the published results were funded by Zukunftsfonds Steiermark. JKM, TRP, and KD are founders of decide Clinical Software GmbH, the developer of GlucoTab. JKM is a shareholder of decide Clinical Software GmbH and elyte diagnostics GmbH and has many advisory board and speaker relationships with diabetes device and drug companies. FA and TRP also declared diabetes-related advisory, consultant, speaker, or shareholder interests. All other authors declared no other conflicts.
The easy way to misread this
Do not conclude that GlucoTab alone caused fewer emergency admissions, lower morning glucose, or fewer nursing visits. The intervention included structured nursing training, physician-guided insulin initiation, and standardized titration protocols, and the study had nine participants, no control group, and no inferential statistics.